Explore complete, patient-level data
Complete, timely, and clean regulatory-grade EHR data
Unlock the power of complete EHR data for research
Truveta, a growing collective of 30 US health systems, offers complete, timely, and clean regulatory-grade EHR data that now includes over 120 million patients. Updated daily for the most current view of patient care, Truveta Data includes more than 5 billion clinical notes, nearly 100 million medical images, and billions of linked claims records.
Advance your research with immediate access to complete patient-level insights, including imaging data, clinical notes, and mother-child pairs.
Safety
HEOR
Public health
Clinical trials
Care quality
Market access
Research & development
Leverage real-world data, powerful analytics, and the Truveta Language model to support therapy development and access, care quality improvement, and public health.
Safety
HEOR
Public health
Clinical trials
Care quality
Market access
Research & development
Study the mother-child relationship with confidence
Study medication safety, the connection between maternal health and childhood conditions, and more, with immunizations and medications during pregnancy, delivery outcomes and complications, labs at time of birth, and more.
The power of clinical notes and images
Truveta Data includes more than 5 billion clinical notes and an extensive collection of medical images, enabling more complete research.
Stage of illness
Treatment, reason for change in treatment regimen
Treatment not considered due to patient preference
Genomic variants
Specific staging information across recurrence staging, clinical staging, and pathology staging
Explore the largest collection of clinical notes integrated with EHR data.
- Migraine frequency and severity
- Crohn’s & ulcerative colitis patient journey
- Myasthenia gravis treatment response
- Seizure frequency
- Cancer stage
Explore the largest collection of clinical notes integrated with EHR data.
- Migraine frequency and severity
- Crohn’s & ulcerative colitis patient journey
- Myasthenia gravis treatment response
- Seizure frequency
- Cancer stage
Stage of illness
Treatment, reason for change in treatment regimen
Treatment not considered due to patient preference
Genomic variants
Specific staging information across recurrence staging, clinical staging, and pathology staging
Learn from millions of medical images integrated with complete EHR data
Truveta Data includes medical images across all modalities, including MRI, CT, X-ray, ultrasound, mammogram, PET, and nuclear medicine, searchable by modality and protocol.
Meet the Johnson & Johnson account management team
Ryan Ahern, M.D.
Chief Medical Officer and co-founder
With more than a decade of experience in healthcare data and clinical research, Ryan leads the Life Science Partner team which focuses on developing new partnerships and ensuring those partners are successful in their research. He is currently a Clinical Assistant Professor of Medicine at the University of Washington School of Medicine and practices at Harborview Medical Center, Seattle’s large county hospital. Prior to this, he trained in internal medicine at the Massachusetts General Hospital and has served as a Clinical Assistant Professor of Medicine at Weill Cornell Medical Center and New York Presbyterian; attending physician at Massachusetts General Hospital; and instructor at Harvard Medical School.
Betsy Wujek
VP Partner Growth – Pharmaceutical & Biotech
Betsy oversees our partnership with Johnson & Johnson and ensuring our mission of Saving Lives with Data comes to life in that our collaboration not only meets immediate needs, but also support Johnson & Johnson’s broader strategic goals. Betsy Wujek is an accomplished leader with over two decades of experience supporting health and life science customers. Her extensive background includes executive roles in driving real-world evidence strategies to answer key business questions across the life science industry.
Jade Denham
Partner Growth Director
Jade leads the collaboration with Johnson & Johnson as the daily, primary point of contact. With a focus on creating meaningful and impactful partnerships, Jade is dedicated to realizing Truveta’s mission of Saving Lives with Data and ensures that the collaboration with Johnson & Johnson addresses complex challenges and creates impactful solutions to better patients outcomes. With almost a decade of supporting life science and biotech clients from bench to beside, Jade is uniquely positioned to understand her clients needs across the drug development lifecycle.
For any questions regarding partnership opportunities, please reach out to Jade directly:
+1 415-408-1006
Colin Taggart
Director, Life Science Research
Colin plays a pivotal role as Johnson & Johnson’s Technical Partner. He supports all new collaborations by aligning J&J’s technical requirements with the value that Truveta’s suite of products can provide, ensuring seamless implementation and long-term partnership success. Colin’s deep understanding of life sciences and technical expertise enables him to bridge gaps between J&J’s needs and Truveta’s innovative solutions, fostering partnerships that drive impactful clinical advancements.Â
Sally Omidvar
VP of Partner Research and Success
Sally is responsible for enabling and supporting the research of Truveta’s customers. Prior to Truveta, Sally was CTO for Healthcare at DataRobot where she worked to develop and expand machine learning use cases among payers, providers, and life science customers, as well as managing large scale COVID-19 engagements with HHS, CDC, and FDA. Prior to DataRobot her work included collaborations with Google and Gavi utilizing artificial intelligence to inform last-mile vaccine logistics and as a researcher at the CDC engaged in international emergency response. She holds advanced degrees in epidemiology, environmental and occupational health, and environmental engineering from Emory and Stanford.
Ready to accelerate your research with complete, clean, and timely regulatory-grade data?
